Gut Microbiome and Childhood Stunting in Low- and Middle-Income Countries

What the review examined

This systematic review by Chibuye and colleagues, published in npj Biofilms and Microbiomes (2024), synthesized human evidence on how gut microbiota composition differs between stunted and non-stunted children under five years of age living in low- and middle-income countries (LMICs). Stunting - defined as a length- or height-for-age Z-score (LAZ/HAZ) below minus two standard deviations - affects roughly one in five children under five worldwide and is a leading cause of impaired physical and cognitive development.

The authors screened the literature systematically and included 14 studies that used high-throughput genomic sequencing, primarily 16S rRNA gene sequencing with some shotgun metagenomics, to profile the gut microbiome from stool or, in some cases, duodenal samples. The studies spanned diverse settings: eight from Asia (Bangladesh, India, Indonesia), five from Africa (Malawi, Zimbabwe, Madagascar, Central African Republic), and two from South America (Peru). By pooling these geographically varied cohorts, the review aimed to identify microbial signatures of stunting that recur across populations rather than reflecting a single locale.

Key findings: pathobionts, butyrate producers, and diversity

The most consistent signal was an over-representation of pathobionts with inflammatory potential in stunted children. Escherichia/Shigella and Campylobacter - taxa capable of secreting toxins and provoking mucosal inflammation - were repeatedly enriched, alongside organisms such as Desulfovibrio. Conversely, stunted children tended to show a depletion of butyrate- and short-chain-fatty-acid-producing commensals, including Faecalibacterium, Megasphaera, and Blautia, which help maintain colonic mucosal health and restrain pro-inflammatory signaling. Ruminococcus was often increased in stunted children.

Diversity results were more nuanced. Most studies found no significant difference in alpha diversity (within-sample richness) between stunted and non-stunted children, and a meta-analysis of Shannon diversity confirmed no clear difference. However, beta diversity (between-sample community structure) was significantly higher in stunted children in four of the seven studies that reported it, suggesting more variable, less stable community configurations. Notably, no single bacterial genus was associated with stunting across all 14 studies, and some genus-level associations were inconsistent or even opposite in direction between cohorts - underscoring that the microbial signature of stunting is a shift in community balance rather than one culprit organism.

A striking recurring feature was the appearance of oropharyngeal (mouth-associated) taxa - such as Veillonella, Gemella, Streptococcus, Neisseria, and Fusobacterium - in the duodenal and fecal samples of stunted children. The authors describe this as a 'decompartmentalization' of the gastrointestinal tract, in which bacteria that normally reside in the upper airway or mouth colonize the small and large intestine, a pattern associated with small intestinal bacterial overgrowth and environmental enteric dysfunction.

Mechanism: enteric dysfunction and the growth axis

The review situates these microbial patterns within environmental enteric dysfunction (EED), a subclinical disorder of the small intestine common in LMICs and driven by repeated exposure to enteric pathogens and fecal contamination in settings with poor water, sanitation, and hygiene. EED is characterized by villous blunting, increased intestinal permeability ('leaky gut'), chronic mucosal inflammation, and impaired nutrient absorption. An inflamed, permeable gut colonized by pathobionts diverts energy and nutrients toward immune activation and away from linear growth.

Butyrate and other short-chain fatty acids produced by commensals such as Faecalibacterium are a key link: they fuel colonocytes, reinforce tight-junction barrier integrity, and dampen inflammation. Their depletion in stunted children plausibly weakens the barrier and amplifies the inflammatory state. Only one included study examined functional metabolic pathways, reporting that pathways for lipid, B-vitamin, and purine/pyrimidine biosynthesis predicted linear growth at earlier ages, while carbohydrate and amino acid degradation pathways predicted growth later - hinting that the microbiome's metabolic output, not just its taxonomy, shapes growth outcomes. The authors are careful to note that these are cross-sectional associations, so whether dysbiosis causes stunting or arises alongside it cannot be settled from this evidence.

Fit with the metal-microbiome-disease axis

The Chibuye review does not itself measure metals, but its findings connect naturally to the metal-microbiome-disease axis through the shared machinery of nutritional immunity and micronutrient malabsorption. Iron and zinc are focal points. EED-driven barrier damage and inflammation impair absorption of these essential trace metals, and studies of EED biomarkers in LMIC children have linked gut inflammation and permeability to lower iron and zinc status - the same micronutrient deficiencies that independently stunt growth and blunt immunity. Dysbiosis and micronutrient deficiency thus reinforce one another.

The pathobiont expansion seen in stunting is itself a story about metal competition. Enterobacteriaceae such as Escherichia/Shigella are prolific siderophore producers, scavenging iron to outcompete commensals - so the iron economy of the inflamed gut can favor exactly the inflammatory taxa the review flags. This has direct public-health resonance: randomized trials of oral iron fortification in LMIC infants (for example, iron-containing micronutrient powders in Kenyan infants) have shown increased Escherichia/Shigella and other enterobacteria, higher fecal calprotectin, and more inflammation and diarrhea - demonstrating that a metal intervention can shift the microbiome toward the stunting-associated pattern. The axis interpretation is therefore that metal exposures and metal deficiencies both act on the gut microbiome, and the resulting dysbiosis is a plausible mediator of growth failure - a hypothesis consistent with, but not proven by, this observational review.

Implications and limitations

For intervention, the review supports a shift away from single-nutrient thinking toward restoring a healthy microbial community. Strategies that suppress pathobionts, support butyrate producers, and repair the gut barrier - improved water, sanitation, and hygiene to reduce pathogen exposure; breastfeeding; and microbiota-directed complementary foods - may address stunting at a mechanistic level that calorie-focused feeding alone has not. Careful attention to how iron and zinc are delivered matters, since the form and dose of supplemental metals can either help or, by feeding pathobionts, harm.

Key limitations temper these conclusions. The 14 studies were heterogeneous in design, sequencing method, age windows, and stunting definitions, and most were cross-sectional, precluding causal inference. The absence of any universal stunting-associated genus and the incongruent genus-level findings reflect both true population differences and methodological variation. Larger longitudinal and interventional studies with metagenomic and metabolomic profiling - and explicit measurement of trace-metal status - are needed to establish whether correcting gut dysbiosis can restore linear growth.